Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

ROCHESTER, N.Y. – October is Breast Cancer Awareness Month, and genetic testing proved to be lifesaving for the women featured in this story. Jodi Lavery discovered she had a BRCA-2 gene mutation, ...

If you have had a cancer case in your family, know what are the chances of you being at risk of cancer.

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

Claudia Christowitz received funding from the National Research Foundation, South Africa. Cancer treatment is becoming more personalised. By considering a patient’s unique genetic and molecular ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

LITTLE ROCK, Ark. (KTHV) - Getting tested for breast and ovarian cancer is an important topic for women and in this Medical Monday segment,Dr. Kay Chandler explains how genetic testing is helpingwomen ...

A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

Genetic tests for cancer on NHS to help families detect ‘Jolie’ gene - Health secretary Wes Streeting has backed the plans ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...